LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
LB Pharmaceuticals named neuropsychiatry expert Dr. Susan G. Kozauer as Chief Medical Officer, bolstering leadership ahead of key Phase 3 schizophrenia trial results.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day